Prenatal DNA Sequencing Market Size, Share, Analysis, Trends, Growth Report, 2032

Prenatal DNA Sequencing Market

Prenatal DNA Sequencing Market - By Application (Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS, Cancer, And Others), By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 - 2032-

Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-4630 Published Date: Apr-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.30 Billion USD 7.46 Billion 13.98% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Prenatal DNA Sequencing Market Revenue, 2016-2025 (USD Million)
    • 2.2. Global Prenatal DNA Sequencing Market: Snapshot
  •  
  • Chapter 3. Prenatal DNA Sequencing Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Prenatal DNA Sequencing Market drivers: Impact analysis
      • 3.2.2. Rising incidences of various chronic diseases like cancer and AIDS
      • 3.2.3. Increase in R&D investment for preventing chronic diseases
      • 3.2.4. Growing technological improvements in DNA sequencing
    • 3.3. Market restraints
      • 3.3.1. The high cost of sequencing
    • 3.4. Opportunities
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Application
      • 3.6.2. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Prenatal DNA Sequencing Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Prenatal DNA Sequencing Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Application Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Prenatal DNA Sequencing Market - Application Analysis
    • 5.1. Global Prenatal DNA Sequencing Market: Application overview
      • 5.1.1. Global Prenatal DNA Sequencing Market share, by Application, 2018 and 2025
    • 5.2. Hemophilia
      • 5.2.1. Global Prenatal DNA Sequencing Market for Hemophilia, 2016-2025 (USD Million)
    • 5.3. Down Syndrome
      • 5.3.1. Global Prenatal DNA Sequencing Market for Down Syndrome, 2016-2025 (USD Million)
    • 5.4. Cystic Fibrosis
      • 5.4.1. Global Prenatal DNA Sequencing Market for Cystic Fibrosis, 2016-2025 (USD Million)
    • 5.5. Autism
      • 5.5.1. Global Prenatal DNA Sequencing Market for Autism, 2016-2025 (USD Million)
    • 5.6. DiGeorge Syndrome
      • 5.6.1. Global Prenatal DNA Sequencing Market for DiGeorge Syndrome, 2016-2025 (USD Million)
    • 5.7. AIDS
      • 5.7.1. Global Prenatal DNA Sequencing Market for AIDS, 2016-2025 (USD Million)
    • 5.8. Cancer
      • 5.8.1. Global Prenatal DNA Sequencing Market for Cancer, 2016-2025 (USD Million)
    • 5.9. Others
      • 5.9.1. Global Prenatal DNA Sequencing Market for Others, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Prenatal DNA Sequencing Market - Regional Analysis
    • 6.1. Global Prenatal DNA Sequencing Market: Regional overview
      • 6.1.1. Global Prenatal DNA Sequencing Market share, by region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.2.2. The U.S.
        • 6.2.2.1. The U.S. Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.2.3. Rest of North America
        • 6.2.3.1. Rest of North America Prenatal DNA Sequencing Market Revenue, by Application,2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.3. The U.K.
        • 6.3.3.1. U.K. Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.5. Rest of Europe
        • 6.3.5.1. Rest of Europe Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.2. China
        • 6.4.2.1. China Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.4. India
        • 6.4.4.1. India Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.5. Rest of Asia Pacific
        • 6.4.5.1. Rest of Asia Pacific Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.5.3. Rest of Latin America
        • 6.5.3.1. Rest of Latin America Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
  •  
  • Chapter 7. Company Profile
    • 7.1. Agilent Technologies
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Application Portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. F. Hoffmann-La Roche
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Application Portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Laboratory Corporation of America
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Application Portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Natera
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Application Portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Genomic Health
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Application Portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Myriad Genetics
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Application Portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. Invitae
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Application Portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. BGI
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Application Portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments
    • 7.9. Illumina
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Application Portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Prenatal DNA Sequencing Market Revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Prenatal DNA Sequencing Market attractiveness analysis, by Application
6. Prenatal DNA Sequencing Market attractiveness analysis, by Region
7. Company market share analysis, 2018
8. Global Prenatal DNA Sequencing Market share by Application, 2018 and 2025
9. Global Prenatal DNA Sequencing Market Revenue for Hemophilia, 2016–2025 (USD Million)
10. Global Prenatal DNA Sequencing Market Revenue for Down Syndrome, 2016–2025 (USD Million)
11. Global Prenatal DNA Sequencing Market Revenue for Cystic Fibrosis, 2016–2025 (USD Million)
12. Global Prenatal DNA Sequencing Market Revenue for Autism, 2016–2025 (USD Million)
13. Global Prenatal DNA Sequencing Market Revenue for DiGeorge Syndrome, 2016–2025 (USD Million)
14. Global Prenatal DNA Sequencing Market Revenue for AIDS, 2016–2025 (USD Million)
15. Global Prenatal DNA Sequencing Market Revenue for cancer, 2016–2025 (USD Million)
16. Global Prenatal DNA Sequencing Market Revenue for Others, 2016–2025 (USD Million)
17. North America Prenatal DNA Sequencing Market Revenue, 2016–2025 (USD Million)
18. Europe Prenatal DNA Sequencing Market Revenue, 2016–2025 (USD Million)
19. Asia Pacific Prenatal DNA Sequencing Market Revenue, 2016–2025 (USD Million)
20. Latin America Prenatal DNA Sequencing Market Revenue, 2016–2025 (USD Million)
21. The Middle East and Africa Prenatal DNA Sequencing Market Revenue, 2016–2025 (USD Million)


Table Of Tables

List of Tables

1. Prenatal DNA Sequencing Market: Market snapshot
2. Drivers of the Global Prenatal DNA Sequencing Market: Impact analysis
3. Restraints of the Global Prenatal DNA Sequencing Market: Impact analysis
4. North America Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
5. The U.S. Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
6. Rest of North America Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
7. Europe Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
8. Germany Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
9. U.K. Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
10. France Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
11. Rest of Europe Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
12. Asia Pacific Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
13. China Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
14. Japan Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
15. India Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
16. Rest of Asia Pacific Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
17. Latin America Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
18. Brazil Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
19. Rest of Latin America Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)
20. The Middle East and Africa Prenatal DNA Sequencing Market Revenue, by Application, 2016–2025 (USD Million)

Methodology

FrequentlyAsked Questions

DNA sequencing of a fetus during pregnancy is called prenatal DNA sequencing. A sample of maternal blood with fetal DNA is taken for non-invasive prenatal testing (NIPT). Advanced sequencing methods like next-generation sequencing (NGS) scan DNA to find genetic variants, chromosomal abnormalities, and other genetic markers linked to inherited disorders. Prenatal DNA sequencing helps pregnant parents and healthcare providers detect and diagnose genetic diseases early and make informed pregnancy management and intervention decisions.

There are various factors driving the prenatal DNA sequencing market globally. The demand for prenatal DNA sequencing technology is increasing rapidly in the global market, due to the introduction of new technologies of DNA sequencing process and increasing incidences of chronic diseases like cancer and AIDS, among others.

According to the report, the global Prenatal DNA Sequencing market size was worth around USD 2.30 billion in 2023 and is predicted to grow to around USD 7.46 billion by 2032.

The global Prenatal DNA Sequencing market is expected to grow at a CAGR of 13.98% during the forecast period.

North America dominates the market due to the rising number of genetic diseases that require an increased number of hospitals for treatment.

Some major players in the prenatal DNA sequencing market are Agilent Technologies, F. Hoffmann-La Roche, Laboratory Corporation of America, Natera, Genomic Health, Myriad Genetics, Invitae, BGI, and Illumina.

The global Prenatal DNA Sequencing market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed